Advertisement

Topics

FDA approves new treatment for most common form of advanced skin cancer

07:49 EDT 24 Jul 2015 | FDA

The U.S. Food and Drug Administration today approved Odomzo (sonidegib) to treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation therapy.

Original Article: FDA approves new treatment for most common form of advanced skin cancer

NEXT ARTICLE

More From BioPortfolio on "FDA approves new treatment for most common form of advanced skin cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...